Esther Ooi

2.9k citations

81 papers · 2.2k indexed · h-index 28

Impact in

Endocrinology, Diabetes and Metabolism top 1%
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diet, Metabolism, and Disease
Surgery top 5%
- Lipoproteins and Cardiovascular Health
- Cholesterol and Lipid Metabolism

Papers in

Transplantation 13
- Renal Transplantation Outcomes and Treatments 13
Endocrinology, Diabetes and Metabolism 50
- Diabetes, Cardiovascular Risks, and Lipoproteins 44

Co-authors: Gerald F. Watts P. Hugh R. Barrett Dick C. Chan T Ng Doris Chan Juying Ji Paul J. Nestel Seng Khee Gan
Journals: The Journal of Clinical Endocrinology & Metabolism (7 papers)Atherosclerosis (6 papers)Journal of Lipid Research (6 papers)Arteriosclerosis Thrombosis and Vascular Biology (5 papers)Clinical Science (4 papers)
Partner nations: Australia United States New Zealand

In The Last Decade

Esther Ooi

80 papers receiving 2.2k citations

Peers

Countries citing papers authored by Esther Ooi

Since Specialization

Citations

This map shows the geographic impact of Esther Ooi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esther Ooi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esther Ooi more than expected).

Fields of papers citing papers by Esther Ooi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Esther Ooi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esther Ooi. The network helps show where Esther Ooi may publish in the future.

Co-authors

The 25 scholars most cited alongside Esther Ooi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Esther Ooi Line = papers co-authored together Esther Ooi links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Comparison Between Antigen and Allelic HLA Mismatches, and the Risk of Acute Rejection in Kidney Transplant Recipients HLA ·Ryan Gately, A. Taverniti, Narelle Watson, Armando Teixeira‐Pinto, Esther Ooi, Rowena Lalji, Ross S. Francis, Lucy C. Sullivan, William R. Mulley, Kate Wyburn, Scott Campbell, Carmel M. Hawley, Germaine Wong, Wai H. Lim	2025	1
2	Clinical Applicability of 2‐Field High‐Resolution and Extended HLA‐Allele Typing in Deceased Donor Kidney Allocation HLA ·Zhan Lim, A. Taverniti, Jonathan Downing, Cindy Le, Pedro López, Nicholas Larkins, Doris Chan, Aron Chakera, Lloyd D’Orsogna, Anoushka Krishnan, Matthew Chau, Esther Ooi, Farzaneh Boroumand, Armando Teixeira‐Pinto, Ryan Gately, Ankit Sharma, Germaine Wong, Wai H. Lim	2024	1
3	Association between diabetic status and risk of all-cause and cause-specific mortality on dialysis following first kidney allograft loss Clinical Kidney Journal ·Amali Samarasinghe, Germaine Wong, Armando Teixeira‐Pinto, David W. Johnson, Carmel M. Hawley, Helen Pilmore, William R. Mulley, Matthew A. Roberts, Kevan R. Polkinghorne, Neil Boudville, Christopher E. Davies, Andrea K. Viecelli, Esther Ooi, Nicholas Larkins, Charmaine E. Lok, Wai H. Lim	2024	1
4	Donors With a Prior History of Cancer: Factors of Non-Utilization of Kidneys for Transplantation Transplant International ·Wai H. Lim, Eric Au, Armando Teixeira‐Pinto, Esther Ooi, Helen Opdam, Jeremy R. Chapman, David W. Johnson, John Kanellis, Christopher E. Davies, Germaine Wong	2023	2
5	The incidence of cancer recurrence and new cancer following commencement of dialysis Clinical Kidney Journal ·Wai H. Lim, Esther Ooi, Aashi Pankaj, Armando Teixeira‐Pinto, Yingxin Lin, David W. Johnson, Carmel M. Hawley, Andrea K. Viecelli, Helen Pilmore, Matthew A. Roberts, Christopher E. Davies, Anoushka Krishnan, Germaine Wong	2022	4
6	Incidence of Major Adverse Cardiovascular Events and Cardiac Mortality in High-Risk Kidney-Only and Simultaneous Pancreas−Kidney Transplant Recipients Kidney International Reports ·Wai H. Lim, Charmaine E. Lok, S. Joseph Kim, Greg Knoll, Baiju R. Shah, Kyla L. Naylor, Eric McArthur, Bin Luo, Stephanie N. Dixon, Carmel M. Hawley, Esther Ooi, Andrea K. Viecelli, Germaine Wong	2021	4
7	Global Epidemiology, Health Outcomes, and Treatment Options for Patients With Type 2 Diabetes and Kidney Failure Frontiers in Clinical Diabetes and Healthcare ·Jessica Phillips, Jenny H. C. Chen, Esther Ooi, Janelle Prunster, Wai H. Lim	2021	5
8	Apolipoprotein(a) Kinetics in Statin-Treated Patients With Elevated Plasma Lipoprotein(a) Concentration The Journal of Clinical Endocrinology & Metabolism ·Louis Ma, Dick C. Chan, Esther Ooi, Santica M. Marcovina, P. Hugh R. Barrett, Gerald F. Watts	2019	13
9	Metabolism and proteomics of large and small dense LDL in combined hyperlipidemia: effects of rosuvastatin Journal of Lipid Research ·Nuntakorn Thongtang, Margaret R. Diffenderfer, Esther Ooi, P. Hugh R. Barrett, Scott Turner, Ngoc‐Anh Le, W. Virgil Brown, Ernst J. Schaefer	2017	44
10	Consumption of a whey protein-enriched diet may prevent hepatic steatosis associated with weight gain in elderly women Nutrition Metabolism and Cardiovascular Diseases ·Esther Ooi, Leon A. Adams, Kexiang Zhu, Joshua R. Lewis, Deborah A. Kerr, Xingqiong Meng, Vicky Solah, Amanda Devine, Colin Binns, Richard L. Prince	2014	13
11	Dose-Dependent Effects of Rosuvastatin on the Plasma Sphingolipidome and Phospholipidome in the Metabolic Syndrome The Journal of Clinical Endocrinology & Metabolism ·T Ng, Esther Ooi, Gerald F. Watts, Dick C. Chan, Jacquelyn M. Weir, Peter J. Meikle, P. Hugh R. Barrett	2014	62
12	HER2 status in gastric/gastro-oesophageal junctional cancers: should determination of gene amplification by SISH use HER2 copy number or HER2:CEP17 ratio? Pathology ·M. Priyanthi Kumarasinghe, W. Bastiaan de Boer, Tze Sheng Khor, Esther Ooi, Nic Jene, Sureshini Jayasinghe, Stephen B. Fox	2014	9
13	Insulin Resistance and the Metabolic Syndrome Are Associated With Arterial Stiffness in Patients With Chronic Kidney Disease American Journal of Hypertension ·Danny Chan, Gerald F. Watts, Ashley Irish, Esther Ooi, Gursharan Dogra	2013	18
14	Elevated interleukin-12 and interleukin-18 in chronic kidney disease are not associated with arterial stiffness Cytokine ·Kenneth Yong, Esther Ooi, Gursharan Dogra, Morgan Mannion, Neil Boudville, Doris Chan, Ee Mun Lim, Wai H. Lim	2013	25
15	Demystifying the management of hypertriglyceridaemia Nature Reviews Cardiology ·Gerald F. Watts, Esther Ooi, Dick C. Chan	2013	83
16	Effects of atorvastatin on human C-reactive protein metabolism Atherosclerosis ·Nuntakorn Thongtang, Margaret R. Diffenderfer, Esther Ooi, Bela F. Asztalos, Gregory G. Dolnikowski, Stefania Lamon‐Fava, Ernst J. Schaefer	2012	9
17	Effects of Therapeutic Lifestyle Change diets high and low in dietary fish-derived FAs on lipoprotein metabolism in middle-aged and elderly subjects Journal of Lipid Research ·Esther Ooi, Alice H. Lichtenstein, John S. Millar, Margaret R. Diffenderfer, Stefania Lamon‐Fava, Helen Rasmussen, Francine K. Welty, P. Hugh R. Barrett, Ernst J. Schaefer	2012	35
18	Chronic kidney disease delays VLDL-apoB-100 particle catabolism: potential role of apolipoprotein C-III Journal of Lipid Research ·Doris Chan, Gursharan Dogra, Ashley Irish, Esther Ooi, P. Hugh R. Barrett, Dick C. Chan, Gerald F. Watts	2009	59
19	An ABC of apolipoprotein C-III: a clinically useful new cardiovascular risk factor? International Journal of Clinical Practice ·Dick C. Chan, M. M. Chen, Esther Ooi, Gerald F. Watts	2008	62
20	High-Density Lipoprotein (HDL) Transport in the Metabolic Syndrome: Application of a New Model for HDL Particle Kinetics The Journal of Clinical Endocrinology & Metabolism ·Juying Ji, Gerald F. Watts, Anthony G. Johnson, Dick C. Chan, Esther Ooi, Kerry‐Anne Rye, Adrian Serone, P. Hugh R. Barrett	2006	39

About Esther Ooi

Esther Ooi is a scholar working on Transplantation, Endocrinology, Diabetes and Metabolism, Cancer Research, Surgery and Nephrology, having authored 81 papers that have together received 2.2k indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (44 papers), Lipoproteins and Cardiovascular Health (34 papers), Cancer, Lipids, and Metabolism (19 papers), Renal Transplantation Outcomes and Treatments (13 papers), Lipid metabolism and disorders (10 papers), Cholesterol and Lipid Metabolism (9 papers), Adipokines, Inflammation, and Metabolic Diseases (7 papers) and Liver Disease Diagnosis and Treatment (7 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (937 citations), Surgery (1.1k citations), Cancer Research (362 citations), Cardiology and Cardiovascular Medicine (539 citations) and Transplantation (52 citations). Esther Ooi has collaborated with scholars based in Australia, United States and New Zealand. Frequent co-authors include Gerald F. Watts, P. Hugh R. Barrett, Dick C. Chan, T Ng, Doris Chan, Juying Ji, Paul J. Nestel, Seng Khee Gan, Gursharan Dogra and Alice H. Lichtenstein. Their work appears in journals such as The Journal of Clinical Endocrinology & Metabolism, Atherosclerosis, Journal of Lipid Research, Arteriosclerosis Thrombosis and Vascular Biology and Clinical Science.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact